USANA Health Sciences, Inc. (USNA) Social Stream
USANA HEALTH SCIENCES INC (USNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering USNA.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-27 | 1 | $90 | $90 | $90 | $62.77 | 43.38% |
2022-02-10 | 2 | $78 | $78 | $78 | $62.77 | 24.26% |
2022-04-14 | 2 | $86 | $78 | $82 | $62.77 | 30.64% |
2022-04-27 | 2 | $78 | $76 | $77 | $62.77 | 22.67% |
2022-07-12 | 2 | $58 | $53 | $55.5 | $62.77 | -11.58% |
2022-07-28 | 2 | $57 | $53 | $55 | $62.77 | -12.38% |
2022-10-27 | 1 | $49 | $49 | $49 | $62.77 | -21.94% |
2023-02-13 | 1 | $52.5 | $52.5 | $52.5 | $62.77 | -16.36% |
2023-04-26 | 1 | $56 | $56 | $56 | $62.77 | -10.79% |
Price Target Last Issued October 27, 2021
The Trend in the Analyst Price Target
Over the past 18 months, USNA's average price target has gone down $34.
Over the past 41 weeks, USNA's average upside potential has been -17.63%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-07-12 | 2 | 58.0 | 53.0 | 55.5 | 67.46 | -17.73% |
2022-07-28 | 1 | 57.0 | 57.0 | 57.0 | 70.16 | -18.76% |
2022-07-28 | 2 | 57.0 | 53.0 | 55.0 | 70.16 | -21.61% |
2022-10-27 | 1 | 49.0 | 49.0 | 49.0 | 55.00 | -10.91% |
2023-02-13 | 1 | 52.5 | 52.5 | 52.5 | 61.12 | -14.1% |
USNA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
USNA's average broker recommendation rating improved by 0 over the prior 32 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for USNA as an investment opportunity.
- In terms of how USANA HEALTH SCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 16.15% of that group.
- In terms of how USANA HEALTH SCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 79.69% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, USANA HEALTH SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 137.49% of them.
- USANA HEALTH SCIENCES INC's average analyst price target is higher than 840.64% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, LNTH, RIOT, and HSKA are the three stocks most similar to USANA HEALTH SCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is USNA a Buy, Hold or Sell? See the POWR Ratings now!